secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXIMUS, INC. (MMS)
CIK:        0001032220
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001032220-23-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maximus Q1 beats, raises FY23 guidance on restart of Medicaid redeterminations
------------------------------------------------------------------------------

- Q1 revenue $1.25B (+8.5% YoY); organic growth 10.3%; adjusted EPS $0.94, down from $1.12.
- FY23 revenue guidance raised to $4.85-$5.0B (from $4.75-$4.90B); adjusted EPS $4.00-$4.30 (from $3.70-$4.00).
- Medicaid redeterminations restart: states can initiate Feb 1, must start by Apr 2023; Maximus expects phase-in Q3, full run-rate Q4.
- U.S. Services segment margin outlook improved to 9%-11% (from 8%-10%) on redetermination restart.
- Q1 free cash flow outflow $150.4M; Jan collections allowed $75M debt repayment; DSO temporarily at 74 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1032220/000103222023000006/0001032220-23-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1032220/000103222023000006/mms-20230208.htm
  HTML page:      https://secwatch.observer/filing/0001032220-23-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer